ReviewSmall (Weinheim an der Bergstrasse, Germany)2026
Active Site Engineering in Fe-N-C for Efficient Oxygen Reduction.
Review in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Developing efficient and stable oxygen reduction reaction (ORR) catalysts is crucial for fuel cell applications. Non-noble metal iron-nitrogen-carbon (Fe-N-C) catalysts, characterized by low cost, high stability, and tunable electronic structure, represent a promising alternative to Pt-based catalysts. Significant progress in improving the ORR performance of Fe-N-C has been achieved through strategies such as support regulation, defect engineering, and composite structure construction. Recently, active site engineering has emerged as a pivotal approach for optimizing catalytic performance by precisely tuning the coordination environment and electronic structure of Fe active centers. This review systematically summarizes the latest advances in the active site engineering of Fe-N-C ORR catalysts, covering single-atom FeN
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.